Characterization of Arrhythmia-induced Cardiomyopathy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Basel, Switzerland
About this trial
The goal of the this observational study is to gather clinically available data on patients presenting with a suspicion for arrhythmia-induced cardiomyopathy (AiCM) at the University Hospital Basel.
Eligibility criteria
Qualifiers
Diagnostic or suspicion of AiCM as presence of specified keyword in patient's file or as screened by colleagues of the internal medicine or cardiology clinics
Signed study consent
Disqualifiers
Patient's active refusal of the general consent of the University Hospital Basel
Age <18 years old
Temporary exclusion criteria: Acute health condition such as myocardial infarction, patients presenting with a major trauma, a sepsis, patients shortly after cardiac surgery, and patients in shock (>100 bpm, <90 systolic BP, evidence of organ dysfunction).
Life expectancy <1 year (palliative, terminal cancer)
Trial design
Treatments tested in this trial
- Data collection: Major adverse cardiovascular event (MACE) assessment questionnaire (prospective part)
- Data collection: Quality of Life (QoL) Questionnaire (prospective part)
- Data collection (retrospective study)
- Data collection (prospective study database)
Treatment groups
2,700 Participants
are divided into 1 treatment groupLocations
1University Hospital Basel, Department of Cardiology4031, Basel Switzerland
Sponsors and collaborators
University Hospital, Basel, Switzerland
Lead sponsor
Source ClinicalTrials.gov